Mitoxantrone Injection – Manufacturer, Supplier & PCD Franchise



Mitoxantrone Injection — available for PCD franchise from Trumac Healthcare

Mitoxantrone Injection

Mitoxantrone — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

Composition: Mitoxantrone
Form: Injection
Class: Anthracenedione — Antineoplastic
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ Available Now

Pricing, brochure & monopoly territory within 24 hrs.

Mitoxantrone Injection is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This injection is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.

Therapeutic Indications
  • Acute myeloid leukaemia
  • Advanced hormone-refractory prostate cancer
  • Metastatic breast cancer and non-Hodgkin's lymphoma
  • Aggressive multiple sclerosis (specialist use)
Mechanism of Action

Mitoxantrone intercalates into DNA and inhibits topoisomerase II, causing DNA strand breaks and halting cell division. It also suppresses immune cell proliferation, the basis for its use in multiple sclerosis.

Dosage & Administration
  • Dosage of Mitoxantrone Injection must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
  • Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
  • Do not exceed the prescribed dose, and complete the full course as advised.
  • Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
  • To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
  • Myelosuppression
  • Nausea and vomiting
  • Hair thinning
  • Blue-green discolouration of urine
  • Cardiotoxicity
Contraindications
  • Pre-existing heart disease; monitor ejection fraction
  • Cumulative dose limits for cardiotoxicity
  • Myelosuppression; monitor blood counts
  • Pregnancy; risk of secondary leukaemia
Storage

Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.

Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the critical care pharma franchise product list (PDF). Comparing companies? See the injectable PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.


For chemists, distributors and doctors: need Mitoxantrone Injection for a PCD franchise or wholesale? Trumac Healthcare checks availability with its WHO-GMP certified partner units and quotes on enquiry – no franchise fee; first order from ₹25,000.

WhatsApp your requirement

See the full injection & PFS range – manufacturer, supplier and PCD franchise: antibiotic, vitamin, pain, anti-emetic, hormone and critical-care injections in vials, ampoules and pre-filled syringes.

PCD Pharma Franchise & Third Party Manufacturing — Mitoxantrone Injection

  • ✓ Made at WHO-GMP certified partner units — every batch QC released
  • ✓ Monopoly PCD franchise rights at district or state level
  • ✓ Third party / contract manufacturing under your own brand
  • ✓ Wholesale and distributor supply against drug licence + GST
  • ✓ Attractive net rates with healthy PTR / PTS margins
  • ✓ Dispatch within 48 hours of payment realisation

Composition: Mitoxantrone. It is a anthracenedione anticancer agent, used for acute myeloid leukaemia and advanced hormone-refractory prostate cancer. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.

PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Mitoxantrone Injection under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.

Frequently Asked Questions

Who manufactures Mitoxantrone Injection in India?

Trumac Healthcare is a supplier of Mitoxantrone Injection in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.

What is Mitoxantrone Injection used for?

Mitoxantrone Injection is used for acute myeloid leukaemia; advanced hormone-refractory prostate cancer; metastatic breast cancer and non-Hodgkin's lymphoma; aggressive multiple sclerosis (specialist use). It should be used as advised by a registered medical practitioner.

Is Mitoxantrone Injection available for PCD pharma franchise on monopoly basis?

Yes. Mitoxantrone Injection is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.

Do you offer Mitoxantrone for third party or contract manufacturing?

Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Mitoxantrone Injection under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.

Can Mitoxantrone Injection be supplied on wholesale or distributor basis?

Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.

What is the therapeutic class of Mitoxantrone?

Mitoxantrone is a anthracenedione anticancer agent (therapeutic class: Anthracenedione — Antineoplastic).

What documentation is provided with each supply?

Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.

How quickly can an order be dispatched?

Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.

Is a prescription required for Mitoxantrone Injection?

Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.

Ready to start your PCD franchise for Mitoxantrone Injection?

Get Pricing & Franchise Terms →